Nextgen Healthcare (NASDAQ:NXGN) Releases Quarterly Earnings Results, Beats Estimates By $0.17 EPS

Nextgen Healthcare (NASDAQ:NXGN) released its quarterly earnings data on Thursday. The company reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.17, MarketWatch Earnings reports. The company had revenue of $130.88 million for the quarter, compared to analyst estimates of $115.11 million. Nextgen Healthcare had a net margin of 1.01% and a return on equity of 10.64%.

NASDAQ NXGN traded up $2.08 during trading on Friday, reaching $14.62. The company’s stock had a trading volume of 1,035,280 shares, compared to its average volume of 254,836. The company has a current ratio of 1.82, a quick ratio of 1.82 and a debt-to-equity ratio of 0.42. The firm has a market capitalization of $975.34 million, a price-to-earnings ratio of 162.44, a price-to-earnings-growth ratio of 5.85 and a beta of 0.99. Nextgen Healthcare has a 12 month low of $5.10 and a 12 month high of $18.49. The firm has a 50 day moving average price of $10.96 and a 200 day moving average price of $11.42.

Several research firms have recently weighed in on NXGN. Piper Sandler boosted their price objective on shares of Nextgen Healthcare from $17.00 to $23.00 and gave the stock an “overweight” rating in a research note on Friday. Wells Fargo & Co restated a “hold” rating on shares of Nextgen Healthcare in a research note on Friday. Deutsche Bank reduced their target price on shares of Nextgen Healthcare from $12.00 to $9.00 and set a “hold” rating for the company in a report on Tuesday, June 2nd. Cantor Fitzgerald lifted their target price on shares of Nextgen Healthcare from $12.00 to $13.00 and gave the stock a “neutral” rating in a report on Friday. Finally, BidaskClub raised shares of Nextgen Healthcare from a “hold” rating to a “buy” rating in a report on Tuesday, July 28th. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $12.46.

About Nextgen Healthcare

NextGen Healthcare, Inc provides software, services, and analytics solutions to medical and dental group practices in the United States. The company's principal products include NextGen Enterprise EHR, which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools.

Read More: Most Volatile Stocks

Earnings History for Nextgen Healthcare (NASDAQ:NXGN)

Receive News & Ratings for Nextgen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nextgen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.